Holdings of NYLIM VP Wellington Small Cap Portfolio
NEW YORK LIFE INVESTMENTS VP FUNDS TRUST ·259 declared positions · as of Mar 31, 2026
Original filing · Net assets 356.4M $ · Ten largest lines: 13 % of the equity sleeve
Sector breakdown
- Financials 1.8 %
- Technology 1.8 %
- Industrials 0.4 %
- Health care 0.3 %
- Unattributed 95.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 98.2 %
- CAD 1.3 %
- SEK 0.5 %
The quoted currency of each line, as declared.
Country breakdown
- US 93.3 %
- IL 1.9 %
- CA 1.5 %
- BM 1.3 %
- KY 1.1 %
- SE 0.5 %
- IE 0.1 %
- CH 0.1 %
- GG 0.1 %
- SG 0.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 242 | 316.2M $ | 93.33 % |
| 2 | IL | 2 | 6.5M $ | 1.93 % |
| 3 | CA | 4 | 5.2M $ | 1.55 % |
| 4 | BM | 3 | 4.5M $ | 1.32 % |
| 5 | KY | 3 | 3.7M $ | 1.09 % |
| 6 | SE | 1 | 1.7M $ | 0.51 % |
| 7 | IE | 1 | 388.1K $ | 0.11 % |
| 8 | CH | 1 | 273.1K $ | 0.08 % |
| 9 | GG | 1 | 181.6K $ | 0.05 % |
| 10 | SG | 1 | 56K $ | 0.02 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 201 | Viridian Therapeutics Inc | 15,148 | 296.3K $ | 0.08 % |
| 202 | CRISPR Therapeutics AG | 5,741 | 273.1K $ | 0.08 % |
| 203 | Dianthus Therapeutics Inc | 3,170 | 266K $ | 0.07 % |
| 204 | Ligand Pharmaceuticals Inc | 1,302 | 259.9K $ | 0.07 % |
| 205 | Mirum Pharmaceuticals Inc | 2,689 | 248.4K $ | 0.07 % |
| 206 | Alight Inc | 425,555 | 248K $ | 0.07 % |
| 207 | Inspire Medical Systems Inc | 4,778 | 246.4K $ | 0.07 % |
| 208 | Indivior Pharmaceuticals Inc | 8,077 | 246.2K $ | 0.07 % |
| 209 | MBX Biosciences Inc | 8,077 | 241.1K $ | 0.07 % |
| 210 | IonQ Inc | 7,844 | 226.1K $ | 0.06 % |
| 211 | Hims & Hers Health Inc | 10,861 | 225.5K $ | 0.06 % |
| 212 | Prestige Consumer Healthcare Inc | 3,368 | 199.6K $ | 0.06 % |
| 213 | Catalyst Pharmaceuticals Inc | 7,650 | 189.4K $ | 0.05 % |
| 214 | Tarsus Pharmaceuticals Inc | 2,648 | 185.8K $ | 0.05 % |
| 215 | Supernus Pharmaceuticals Inc | 3,577 | 184.9K $ | 0.05 % |
| 216 | Twist Bioscience Corp | 3,883 | 184.5K $ | 0.05 % |
| 217 | Erasca Inc | 11,347 | 183.6K $ | 0.05 % |
| 218 | ACADIA Pharmaceuticals Inc | 8,229 | 183.2K $ | 0.05 % |
| 219 | Genius Sports Ltd | 40,990 | 181.6K $ | 0.05 % |
| 220 | Ideaya Biosciences Inc | 5,409 | 180.2K $ | 0.05 % |
| 221 | Arcutis Biotherapeutics Inc | 7,262 | 171.1K $ | 0.05 % |
| 222 | ImmunityBio Inc | 22,038 | 169K $ | 0.05 % |
| 223 | Denali Therapeutics Inc | 8,786 | 168.7K $ | 0.05 % |
| 224 | Travere Therapeutics Inc | 5,673 | 168.5K $ | 0.05 % |
| 225 | Veracyte Inc | 5,189 | 167.1K $ | 0.05 % |
| 226 | Janus Living Inc | 7,000 | 165K $ | 0.05 % |
| 227 | Liquidia Corp | 4,160 | 157K $ | 0.04 % |
| 228 | BioCryst Pharmaceuticals Inc | 16,132 | 153.6K $ | 0.04 % |
| 229 | Beam Therapeutics Inc | 6,392 | 152.3K $ | 0.04 % |
| 230 | Vera Therapeutics Inc | 3,773 | 151.8K $ | 0.04 % |
| 231 | Dyne Therapeutics Inc | 8,048 | 145.9K $ | 0.04 % |
| 232 | Edgewise Therapeutics Inc | 4,513 | 142.2K $ | 0.04 % |
| 233 | ADMA Biologics Inc | 15,676 | 141.2K $ | 0.04 % |
| 234 | Syndax Pharmaceuticals Inc | 5,755 | 134.4K $ | 0.04 % |
| 235 | Immunome Inc | 6,040 | 132.1K $ | 0.04 % |
| 236 | Agios Pharmaceuticals Inc | 3,801 | 128.6K $ | 0.04 % |
| 237 | Amneal Pharmaceuticals Inc | 10,284 | 127.8K $ | 0.04 % |
| 238 | Oruka Therapeutics Inc | 2,486 | 121.9K $ | 0.03 % |
| 239 | GRAIL Inc | 2,350 | 121.4K $ | 0.03 % |
| 240 | Definium Therapeutics Inc | 6,314 | 119.3K $ | 0.03 % |
| 241 | Immunovant Inc | 4,696 | 116.6K $ | 0.03 % |
| 242 | Arcus Biosciences Inc | 5,363 | 115.8K $ | 0.03 % |
| 243 | Aurinia Pharmaceuticals Inc | 7,650 | 113.4K $ | 0.03 % |
| 244 | Vericel Corp | 3,417 | 109.9K $ | 0.03 % |
| 245 | Ocular Therapeutix Inc | 12,407 | 105.1K $ | 0.03 % |
| 246 | Nurix Therapeutics Inc | 6,654 | 103.1K $ | 0.03 % |
| 247 | Innoviva Inc | 4,191 | 97.7K $ | 0.03 % |
| 248 | Stoke Therapeutics Inc | 2,998 | 97.6K $ | 0.03 % |
| 249 | Relay Therapeutics Inc | 9,797 | 97.5K $ | 0.03 % |
| 250 | ANI Pharmaceuticals Inc | 1,233 | 94.8K $ | 0.03 % |
| 251 | Ardelyx Inc | 15,671 | 93.9K $ | 0.03 % |
| 252 | Intellia Therapeutics Inc | 6,974 | 89.4K $ | 0.03 % |
| 253 | Alumis Inc | 3,736 | 82.3K $ | 0.02 % |
| 254 | Novavax Inc | 9,871 | 80.3K $ | 0.02 % |
| 255 | Recursion Pharmaceuticals Inc | 24,930 | 76.5K $ | 0.02 % |
| 256 | Collegium Pharmaceutical Inc | 2,174 | 71.9K $ | 0.02 % |
| 257 | EyePoint Inc | 5,387 | 69.4K $ | 0.02 % |
| 258 | Olema Pharmaceuticals Inc | 3,873 | 57.7K $ | 0.02 % |
| 259 | WaVe Life Sciences Ltd | 7,719 | 56K $ | 0.02 % |